Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference

    Insights

    Cirrhosis causes complex hemostatic alterations, rebalancing the blood clotting system. This consensus outlines optimal management for bleeding and thrombosis risks in cirrhotic patients.

    Area of Science:

    • Hepatology
    • Hematology
    • Internal Medicine

    Background:

    • Patients with cirrhosis exhibit altered hemostasis due to reduced pro-coagulant and anti-coagulant factors, leading to a rebalanced system.
    • Understanding these hemostatic perturbations is crucial for managing bleeding and thrombotic risks.

    Framework:

    • A consensus conference was convened by the Italian Association of the Study of the Liver (AISF) and the Italian Society of Internal Medicine (SIMI).
    • The process involved a literature review by experts, a formal consensus meeting, and grading of statements by evidence quality and recommendation strength.
    • An independent jury approved the final consensus statements.

    Implementation:

    • The consensus evaluates the strengths and weaknesses of current laboratory tests for assessing bleeding and thrombotic risk in cirrhosis.
    • It details the pathophysiology of hemostatic changes in liver cirrhosis.
    • The statements provide guidance on the optimal management of bleeding and thrombosis.

    Implications:

    • This consensus offers a framework for improved diagnosis and management of hemostatic disorders in cirrhotic patients.
    • It aims to enhance clinical decision-making regarding bleeding and thrombosis in liver cirrhosis.
    • The findings support evidence-based practice for managing hemostatic balance in this patient population.

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    333
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    256
    Esophageal Varices-II: Clinical Features and Management01:28

    Esophageal Varices-II: Clinical Features and Management

    Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
    In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
    744
    Liver Physiology01:30

    Liver Physiology

    The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
    Metabolic Regulation:
    The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
    4.2K
    Disorders of Hemostasis01:24

    Disorders of Hemostasis

    Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
    Thromboembolic Disorders
    Two factors primarily cause thromboembolic conditions.
    2.7K
    Extrinsic and Intrinsic Pathways of Hemostasis01:20

    Extrinsic and Intrinsic Pathways of Hemostasis

    Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
    The Extrinsic Pathway
    The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
    15.1K